FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is a drug film of prolonged action, which contains the main component in the form of a 30 % aqueous solution of gelatin, auxiliary and drug components. As auxiliary components it contains a 20 % solution of human albumin, saline, powdered polyvinylpyrrolidone, collagen, fibrinogen, thrombin. As a drug component it contains a biologically active substance – vascular endothelial growth factor (VEGF) in the following ratio, wt. parts: 30 % aqueous solution of gelatin – 1.5, 20 % solution of human albumin – 1.0, polyvinylpyrrolidone – 0.1, collagen – 3.0, fibrinogen – 0.125, thrombin – 1.0, vascular endothelial growth factor (VEGF) – 0.02, saline – 10.0. Described is a method for producing a drug film, which provides the possibility of an effective concentration of the active substance in the blood for 7 days.
EFFECT: film does not prevent the fusion of the wound edges with each other, contributes to the epithelization of the wound edges on the 7th day of the study.
2 cl, 4 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PROLONGED-RELEASE MEDICATED FILM, METHOD FOR PREPARING AND APPLYING IT | 2010 |
|
RU2445074C1 |
PHARMACEUTICAL COMPOSITION FOR PRODUCING A LYOPHILISATE OF LIVER CELL CULTURE ENRICHED WITH HEPATOCYTE GROWTH FACTOR | 2021 |
|
RU2781448C1 |
DENTAL PRODUCT IN FORM OF PHYTOFILM | 2020 |
|
RU2749710C1 |
METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
BIODEGRADABLE WOUND-HEALING FILM | 2022 |
|
RU2789304C1 |
METHOD FOR PREVENTION OF CHRONIC SUBLEME COAGULOPATHY IN RATS IN EXPERIMENT | 2022 |
|
RU2788609C1 |
AGENT WITH ANTITHROMBOTIC ACTIVITY | 2016 |
|
RU2627435C1 |
ALPHA-2-INTERFERON-BASED ANTIVIRAL AGENT IN CREAM FORM | 1998 |
|
RU2159609C2 |
METHOD OF MODELING OF CHRONIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2020 |
|
RU2746831C1 |
Authors
Dates
2019-01-24—Published
2018-07-27—Filed